Wednesday, November 14, 2018
The title of this post is the title of this interesting new research in the journal Social Science Quarterly authored by Laurel Elder and Steven Greene. Here is its abstract:
The objectives of this study were to understand why, even though women are more liberal than men on a broad range of issues, when it comes to the increasingly prominent issue of marijuana legalization, the direction of the gender gap is reversed, with women more conservative than men.
Relying on a 2013 Pew survey — unique for the extensiveness of its marijuana questions, including marijuana usage — we explore and attempt to explain the nature of this unusual gender gap. We test several hypotheses rooted in the different life experiences of women and men.
We find that women's role as mothers cannot explain this gap, and that mothers are in fact no different from those without children in terms of their support for marijuana policy, as well as their reported use of marijuana. The greater religiosity of women does play a prominent role in the gender gap on marijuana policy, but does not account for the full difference of opinion between women and men. Our findings suggest that men's greater propensity relative to women to use marijuana is a major driver behind the gender gap.
Not only are attitudes on marijuana legalization likely to continue to liberalize, but as marijuana legalization and marijuana use become normalized, rather than viewed as immoral and dangerous behavior, the existing gender gap should shrink.
Tuesday, October 30, 2018
"One Month of Cannabis Abstinence in Adolescents and Young Adults Is Associated With Improved Memory"
The title of this post is the title of this new research appearing in the Journal of Clinical Psychiatry. Here is its abstract:
Objective: Associations between adolescent cannabis use and poor neurocognitive functioning have been reported from cross-sectional studies that cannot determine causality. Prospective designs can assess whether extended cannabis abstinence has a beneficial effect on cognition.
Methods: Eighty-eight adolescents and young adults (aged 16–25 years) who used cannabis regularly were recruited from the community and a local high school between July 2015 and December 2016. Participants were randomly assigned to 4 weeks of cannabis abstinence, verified by decreasing 11-nor-9-carboxy-∆9-tetrahydrocannabinol urine concentration (MJ-Abst; n = 62), or a monitoring control condition with no abstinence requirement (MJ-Mon; n = 26). Attention and memory were assessed at baseline and weekly for 4 weeks with the Cambridge Neuropsychological Test Automated Battery.
Results: Among MJ-Abst participants, 55 (88.7%) met a priori criteria for biochemically confirmed 30-day continuous abstinence. There was an effect of abstinence on verbal memory (P = .002) that was consistent across 4 weeks of abstinence, with no time-by-abstinence interaction, and was driven by improved verbal learning in the first week of abstinence. MJ-Abst participants had better memory overall and at weeks 1, 2, 3 than MJ-Mon participants, and only MJ-Abst participants improved in memory from baseline to week 1. There was no effect of abstinence on attention: both groups improved similarly, consistent with a practice effect.
Conclusions: This study suggests that cannabis abstinence is associated with improvements in verbal learning that appear to occur largely in the first week following last use. Future studies are needed to determine whether the improvement in cognition with abstinence is associated with improvement in academic and other functional outcomes.
Monday, October 29, 2018
Colorado Division of Criminal Justice publishes huge new report on "Impacts of Marijuana Legalization in Colorado"
As detailed in this press release, on Friday October 26, the "Colorado Division of Criminal Justice Office of Research and Statistics ... released 'Impacts on Marijuana Legalization in Colorado,' a report that compiles and analyzes data on marijuana-related topics including crime, impaired driving, hospitalizations and ER visits, usage rates, effects on youth, and more." Here a partial summary of the 250+ page report via parts of the press release:
Data suggests that law enforcement and prosecutors are aggressively pursuing cases against black market activity. The quantity of cases filed for serious marijuana-related crimes has remained consistent with pre-legalization levels, however organized crime cases have generally increased since 2008.
Felony marijuana court case filings (conspiracy, manufacturing, distribution, and possession with intent to sell) declined from 2008 to 2014, but increased from 2015 through 2017.
The most recent increase in filings might be in part because legislation changed the legal indoor plant count, providing law enforcement agencies with greater clarity and tools to increase their enforcement of black market activity.
Felony filings in 2017 (907) were still below 2008 filings (1,431).
Filings in organized-crime cases followed a similar pattern, with a dip in 2012 and 2013 followed by a significant increase since 2014.
There were 31 organized crime case filings in 2012 and 119 in 2017.
Filings for juveniles under 18 remain at the same level as pre-legalization.
DUI & TRAFFIC FATALITIES
The impact of marijuana consumption on the safety of drivers is a major focus, as any fatality on our roadways is a concern. More data about the impairing effects of marijuana and more consistent testing of drivers for marijuana are needed to truly understand the scope of marijuana impairment and its relation to non-fatal crashes.
The number of trained Drug Recognition Experts increased from 129 in 2012 to 214 in 2018, a 66% increase. Thousands of additional officers have been trained in Advanced Roadside Impairment Detection.
Colorado State Patrol (CSP) DUI cases overall were down 15% from 2014 to 2017.
The percentage of CSP citations with marijuana-only impairment has stayed steady, at around 7%. The percentage of CSP citations with any marijuana nexus rose from 12% in 2012 to 17% in 2016, then dropped to 15% in 2017.
About 10% of people in treatment for a DUI self-reported marijuana as their primary drug of abuse, compared to 86% who report alcohol as their primary drug of abuse.
The percent of drivers in fatal crashes who tested positive for Delta-9 THC at the 5ng/mL level decreased from 11.6% in 2016 to 7.5% in 2017.
The number of fatalities where a driver tested positive for any cannabinoid (Delta 9 or any other metabolite) increased from 55 (11% of all fatalities) in 2013 to 139 (21% of all fatalities) in 2017....
HOSPITALIZATIONS & ER VISITS
These are critical data points so we can track harmful exposure to children, inappropriate usage, and other drivers of marijuana-related hospitalizations.These and related data points prompted legislative and regulatory developments between 2014 and 2016, including child-resistant packaging requirements, requirements for edibles to be marked with a universal symbol so they can be identified even outside their packaging, limitations on the total amount of active THC in an individual retail marijuana edible, and prohibitions on the manufacturing and sales of edibles in the shape of a human, animal, or fruit.
Rates of hospitalization with possible marijuana exposures increased steadily from 2000 through 2015.
Human marijuana exposures reported to the Rocky Mountain Poison and Drug Center increased significantly from pre-legalization to 2014, then flattened out from 2014-2017.
SCHOOL DISCIPLINE & ACHIEVEMENT
New data points are helping us gain a better understanding of school discipline; overall the state is not seeing an impact of recreational marijuana use on high school graduation and drop-out rates.
The total number of suspensions, expulsions, and law enforcement referrals for any reason has remained consistent post-legalization.
Marijuana was the most common single reason for school expulsions (22%) and law enforcement referrals (24%) in the 2016-17 school year, the first full year where marijuana was reported separately as a reason for disciplinary action.
Graduation rates are up and drop-out rates are down since 2012. The Graduation rate rose steadily from a 10-year low point of 72 percent in the 2009-2010 school year to 79 percent in the 2016-2017 school year. Over that same time period, the drop-out rate decreased from 3.1 percent to 2.3 percent.
YOUTH USAGE & ATTITUDES (12-17 years)
Surveys show Colorado is not experiencing an increase in youth usage of marijuana. Preventing negative impacts on youth has been a focus of various state efforts, including public education campaigns that raise awareness about the health and legal consequences of teen marijuana use. The Marijuana Impacts report compiles and analyzes data previously released in the National Survey on Drug Use and Health (NSDUH) and the Healthy Kids Colorado Survey (HKCS) to examine trends related to youth usage and impacts.
The youth marijuana rate reported via NSDUH for the 2015/16 school year (9.1%) was the lowest it’s been since 2007/08 (9.1%).
According to HKCS, the proportion of high school students reporting using marijuana ever in their lifetime or reporting past 30-day use remained statistically unchanged from 2005 to 2017.
According to HKCS, the proportion of students trying marijuana before age 13 went down from 9.2% in 2015 to 6.5% in 2017.
Alcohol was the most common substance students reported using at any point in their lives (59%) followed by e-cigarettes (44%) and then marijuana (35%).
Sunday, October 28, 2018
The folks at PoliFact have this lengthy new piece under the headline "Marijuana legalization in 5 charts: A 2018 midterm report" that is worth reading in full. This infographic under the title "Potential $7 Billion Recreational Marijuana Tax Revenue, By State," highlighting revenue from marijuana reform is alone worth the click-through, and here are excerpts from the piece providing a glimpse at what the "5 charts" cover:
About two in three Americans now favor marijuana legalization, a record-high measure of public support for a drug the federal government still puts in the same category as LSD and heroin.
With a majority of states now permitting legal use in some form, and several states poised to relax their laws this November, we decided to take a graphical look at the country’s most popular illicit drug.
Experts pointed to a number of reasons to explain the dramatic shift in Americans’ opinion of marijuana legalization over a relatively short timespan....
State marijuana laws
American laws around marijuana are complicated....
State tax revenue
Taxing marijuana can yield a large pot of money for states. The data is still somewhat scarce given that legalization is still in its infancy....
The country’s decades-long crackdown on drugs has had a disproportionate impact on minorities....
Some experts said the pros of legalization far outweighed the cons, while others said it’s too early to tell....
October 28, 2018 in Criminal justice developments and reforms, History of Marijuana Laws in the United States, Polling data and results, Recreational Marijuana Data and Research, Taxation information and issues | Permalink | Comments (0)
Sunday, October 21, 2018
The title of this post is the title of this new paper on SSRN authored by Benjamin J. McMichael, R. Van Horn and W. Kip Viscusi. Here is its abstract:
While recent research has shown that cannabis access laws can reduce the use of prescription opioids, the effect of these laws on opioid use is not well understood for all dimensions of use and for the general United States population. Analyzing a dataset of over 1.3 billion individual opioid prescriptions between 2011 and 2017, which were aggregated to the individual provider-year level, we find that recreational and medical cannabis access laws reduce the number of morphine milligram equivalents prescribed each year by 6.9 and 6.1 percent, respectively. These laws also reduce the total days supply of opioids prescribed, the total number of patients receiving opioids, and the probability a provider prescribes any opioids net of any offsetting effects. Additionally, we find consistent evidence that cannabis access laws have different effects across types of providers and physician specialties.
Tuesday, October 16, 2018
The title of this post is the title of this interesting new article in the journal Population Health Management authored by Yulia Treister-Goltzman, Tamar Freud, Yan Press, and Roni Peleg. Here is its abstract:
Widespread use of cannabis as a drug and passage of legislation on its use should lead to an increase in the number of scientific publications on cannabis. The aim of this study was to compare trends in scientific publication for papers on medical cannabis, papers on cannabis in general, and all papers between the years 2000 and 2017. A search of PubMed and Web of Science was conducted.
The overall number of scientific publications in PubMed increased 2.5-fold. In contrast, the number of publications on cannabis increased 4.5-fold and the number of publications on medical cannabis increased almost 9-fold. The number of publications on medical cannabis in Web of science increased even more (10-fold). The most significant number of publications was in the field of psychiatry. In the fields of neurology and cancer treatment there was a significant increase in the years 2011–2013. There was a rise in the number of publications on children and the elderly after 2013. The specific indications with the largest number of publications were HIV (261), chronic pain (179), multiple sclerosis (118), nausea and vomiting (102), and epilepsy (88). More than half of the publications on medical cannabis originated from the United States, followed by Canada. More than 66% of the publications were original studies.
The spike in the number of scientific publications on medical cannabis since 2013 is encouraging. In light of this trend the authors expect an even greater increase in the number of publications in this area in coming years.
Wednesday, October 3, 2018
Prediction of hundreds of millions in tax revenues for Michigan if citizens vote for marijuana legalization
This local article, headlined "Estimated tax haul from marijuana sales would grow to $134 million per year," reports on a report on tax revenues being predicted if Michigan were this fall to become the 10th in the United States to legalize recreational marijuana. Here are some details:
By the time Michigan’s recreational marijuana market is fully fleshed out, $134.5 million in tax revenues will be flowing into the state’s coffers annually. But there’s a big caveat: Michigan voters will first have to pass a ballot proposal on Nov. 6 to legalize marijuana for adult recreational use.
The figures for state tax revenues — from the 6-percent sales tax and a 10-percent excise tax — come from VS Strategies, a Colorado-based cannabis consulting firm hired by the Coalition to Regulate Marijuana Like Alcohol, which is spearheading the campaign to legalize pot in Michigan. “We’re estimating $520 million in taxes from 2020-24,” said Andrew Livingston, a policy analyst with VS Strategies. “By 2023, Michigan will reach maturity with sales of just under $1.5 billion (for both medical and recreational marijuana).”
The revenues from recreational use will grow from $53.7 million in the first year to $134 million by the time the market matures, he said. When you add in the 6 percent sales tax and 3 percent excise tax on medical marijuana sales, the tax revenues jump another $40 million, according to the VS estimates.
The numbers are based on estimates of nearly 1 million Michiganders who have said that they’ve used marijuana in the past month and who could be expected to buy marijuana on a regular basis. Another 3.5 million people in Michigan have said they have used marijuana in their lifetime. The total number of marijuana users includes 300,000 people who are registered as medical marijuana users, Livingston said. Michigan’s tax rate is far lower than many of the other nine states that have legalized pot for recreational use... Michigan’s proposed rate is lower than other states in order to be more competitive and to attract more people to the state’s budding marijuana market, coalition spokesman Josh Hovey said.
The first $20 million in tax revenues for each of the first two years would go to research into the effects of marijuana use on different health ailments, including PTSD in veterans. Of the remainder, 35 percent would go toward roads, 35 percent to schools and 30 percent to the counties and communities that allowed marijuana businesses in their towns.
But the projected tax revenues, even when the market is fully established, fall well below the taxes generated in Colorado, the first state to legalize marijuana for recreational use, which collected $247.3 million in taxes in 2017.
Livingston said the Western states have higher numbers of users and he doesn’t expect Michigan to exceed those numbers. According to the annual National Survey on Drug Use and Health done for the U.S. Department of Health and Human Services in 2016, about 14.4 percent of Colorado’s population, or 727,000 people, used marijuana in the past month while 8.9 percent of Michigan’s population, or 886,000 people, used marijuana in the past month. “Mountain states have always led the rates of past-month consumption,” he said.
Michiganders shouldn’t just look at the tax revenues coming in from marijuana legalization, said Scott Greenlee, director of Healthy and Productive Michigan, a group opposing the ballot proposal. “What impact would it have in Michigan with a $57-billion budget? It’s just not that significant,” he said. “And then we have to deal with the unintended consequences of fighting increased addiction. I wonder if there would be anything left for Michigan other than a bad policy that will affect the state for decades to come.”
He said the 35 percent of tax revenues that would go toward improving Michigan’s roads would be a drop in the bucket for the state’s 120,000 miles of roads. “According to MDOT, the cost to improve roads is about $1 million per lane,” Greenlee said. “In their best case scenario, 35 miles of one lane of roads would be improved thanks to this new tax.”
Hovey said the coalition never promised that the marijuana tax revenues would be a cure-all for Michigan’s budget woes. “This will help fund the state’s most important needs. And we’ll be saving millions in wasted costs of continuing to enforce the prohibition of marijuana laws,” he said. “And I think the majority of the state’s residents would agree that our roads need more revenue.”
October 3, 2018 in Initiative reforms in states, Recreational Marijuana Data and Research, Recreational Marijuana State Laws and Reforms, Taxation information and issues , Who decides | Permalink | Comments (0)
Monday, September 24, 2018
Over at Forbes, Tom Angell has already mined the latest new FBI crime data to focus on marijuana arrests via this piece headlined "Marijuana Arrests Are Increasing Despite Legalization, New FBI Data Shows." Here are excerpts:
Marijuana arrests are rising in the U.S., even as more states legalize cannabis. There is now an average of one marijuana bust roughly every 48 seconds, according to a new FBI report released on Monday.
The increase in marijuana arrests — 659,700 in 2017, compared to 653,249 in 2016 — is driven by enforcement against people merely possessing the drug as opposed to selling or growing it, the data shows.
Last year, there were 599,282 marijuana possession arrests in the country, up from 587,516 in 2016. Meanwhile, busts for cannabis sales and manufacturing dropped, from 65,734 in 2016 to 60,418 in 2017.
The increase in cannabis possession arrests comes despite the fact that four additional states legalized marijuana on Election Day 2016. While among those states, legal recreational sales were only in effect in Nevada by the end of 2017, the prohibition on possession for adults was lifted soon after the successful votes there as well as in California, Maine and Massachusetts....
Overall, marijuana arrests made up 40.4% of the nation's 1,632,921 drug arrests in 2017. Drug arrests as a whole also increased last year, up from 1,572,579 in 2016. There is now a drug bust every 19 seconds in the U.S.
As with all data, there are lots of stories and possible spins within. Though overall marijuana arrests went up, this was because possession arrests went up (only) 2% while arrests for more serious marijuana offenses went down 8%. Given the reality that a lot more people had access to "legal" marijuana but were still not allowed to use it in public spaces and a lot more people were involved in marijuana manufacturing and sales under state laws, these national data probably can and should be seen as evidence that marijuana reform is "working" to some extent to reduce the criminal justice footprint of marijuana prohibition.
Sunday, September 23, 2018
the title of this post is the title of this new paper now available via SSRN authored by Brett Hollenbeck and Kosuke Uetake. Here is its abstract:
In 2012 the state of Washington created a legal framework for production and retail sales of marijuana. Eight other states have subsequently followed. These states hope to generate tax revenue for their state budgets while limiting harms associated with marijuana consumption. We use a unique dataset containing all transactions in the history of the industry in Washington to evaluate the effectiveness of different tax and regulatory policies under consideration by policymakers and study the role of imperfect competition in determining these results.
We document that overall demand is relatively inelastic, that restrictions on entry result in retailers with significant market power, and that cost shocks are more than fully passed through from retailers to consumers. We combine these empirical estimates to calculate the relationship between revenue and the tax rate, the dead-weight loss of taxation and the share of the tax burden that falls on consumers and producers, each of which are significantly effect by imperfect competition.
We find that despite having the nation's highest tax rate, Washington still has significant scope to increase revenues by raising the tax rate on retail marijuana sales. That is, they are still on the upward sloping portion of the laffer curve. The amount of revenue generated by a given tax increase is also significantly larger due to retailer market power than it would be under perfect competition. We also find significant social costs of taxation, roughly 2 dollars are lost to consumers and producers for every dollar of tax revenue generated.
Monday, September 17, 2018
Attorney General Jeff Sessions today delivered these remarks at a National Highway Traffic Safety Administration event titled "Ideas to Impact: A Dialogue to Address Drug-Impaired Driving." Here are excerpts:
It is especially important that we get the word out about this because currently there is a great deal of misinformation and misunderstanding out there. Some even seem to suggest that marijuana and other drugs do not pose accident risks.
In recent years, a number of states have repealed their prohibitions on marijuana use. As a result, too many people think that marijuana is legal and that it is even legal to drive under the influence of marijuana.
That’s wrong. Federal law has not changed and drugged driving laws have not changed. Drugged driving is illegal on every inch of American soil. People need to understand that.
There is another common myth out there, as well: that marijuana doesn’t impair driving. That’s also wrong. Marijuana use slows reaction time and inhibits motor coordination and decision-making abilities. That makes driving much more dangerous.
The bottom line is this: if you’re driving under the influence of drugs, including marijuana, then you’re risking your life — and the life of everyone else on the road.
One European study found that drivers high on marijuana were twice as likely to be responsible for a fatal crash as a sober driver.
Here in this country, the Governors Highway Safety Association put out a report back in May that says that — of those who are tested for drugs or alcohol — more drivers killed in car accidents last year tested positive for drugs than for alcohol. And by far the most common drug was marijuana, not opioids. Nearly a quarter of all drivers killed in car accidents who were tested had marijuana in their system — twice as many as tested positive for opioids.
In recent years, it has been getting worse. According to last year’s version of the report, the number of drivers killed in car accidents who tested positive for marijuana increased by nearly one-fifth from 2006 to 2016.
According to the Denver Post, the number of drivers killed in car accidents in Colorado who tested positive for marijuana doubled from 2013 to 2016. And so, in addition to the hundreds of thousands of Americans who have died of drug overdoses in recent years, another several thousand have died because of drug-impaired driving — either their own or that of someone else.
Wednesday, September 12, 2018
The latest issue of the International Review of Psychiatry has a collection of interesting looking articles with titles like "Marijuana matters: reviewing the impact of marijuana on cognition, brain structure and function, & exploring policy implications and barriers to research" and "Sweet flowers are slow, and weeds make haste: leveraging methodology from research on tobacco, alcohol, and opioid analgesics to make rapid and policy-relevant advances in cannabis science." There are too many interesting looking pieces to cite them all here, but I can quote the start of the editorial introduction:
The allowance of cannabis to be used as a medicine in the absence of adequate data to inform basic clinical decision-making is rooted in compassion for individuals with life-threatening illness, or substantially debilitating illness, and no other course for treatment. However, this relatively simple tenet has now morphed into a large-scale for-profit industry that is fraught with public health concerns. Access to cannabis has been expanded to include treatment for a multitude of health conditions, many of which are neither life-threatening nor debilitating, and for which effective alternative treatments exist. Data from which to determine the risk-benefit for an individual considering the use of cannabis is sparse at best. Quality control issues abound in this industry as there are no established standards for cultivating, processing, testing, or labeling cannabis products. There is also concern over advertisements and product labeling that include misleading or unsubstantiated health claims, as these products have not been vetted by traditional drug development methods. The speed in which cannabis policies are changing is rapid, and the fact that these are happening as a direct result of legislation or by voter referendum is reckless given the absence of consensus standards and, in many cases, appropriate regulatory oversight. The impact of revised cannabis laws, both with respect to medicinal use for a variety of health conditions, and for non-medicinal (aka ‘recreational’) use of cannabis by adults, will likely have a substantial impact on psychiatry.
This special issue of the International Review of Psychiatry is focused on cannabis science, but with a very targeted theme of cannabis regulatory science. Recently in the US, the Food and Drug Administration (FDA) was granted regulatory authority over all nicotine and tobacco products. This was a landmark event, and has engendered a bolus of thoughtful, policy-oriented research that has already resulted in tobacco regulations which are likely to positively impact public health in the US and abroad. Studies have included careful scientific evaluation of the impact of nicotine on cigarette reinforcement and self-administration, packaging and flavoring on youth initiation, the harm reduction effects associated with nicotine delivery devices other than cigarettes, and other important topics. The parallel need for a cannabis regulatory science is urgent. Novel products and cannabis delivery devices are rolling onto the shelves of dispensaries at a rapid rate, product development appears to be geared towards high potency/high dose products, and it is all being carefully marketed to increase consumption. Contributions in this issue highlight lessons learned from tobacco, alcohol, and opioid regulatory science that are relevant to cannabis, detail important factors surrounding tobacco and cannabis co-use, and detail the potential impacts of regulatory changes on cannabis use in the workplace.
September 12, 2018 in Medical Marijuana Commentary and Debate, Medical Marijuana Data and Research, Recreational Marijuana Commentary and Debate, Recreational Marijuana Data and Research | Permalink | Comments (0)
Monday, September 10, 2018
The current (September 2018) issue of JAMA Internal Medicine has three very short pieces (a comment and two replies) discussing and debating research concerning the connection between marijuana reforms and opioid overdose deaths:
Opioid Death Rate Acceleration in Jurisdictions Legalizing Marijuana Use by Archie Bleyer, MD; Brian Barnes, CSWA, MAC, CADC III
The first of these pieces asserts that the "opioid crisis appears to be worsening where marijuana has been legalized, despite fewer opioid prescriptions, and as such, constitutes evidence for the gateway hypothesis and against the marijuana protection hypothesis." The other two pieces sharply take issue with the claims for the first one.
Tuesday, August 28, 2018
This new piece by multiple authors appearing in the Annals of Internal Medicine provides an interesting snapshot of marijuana use and users based on a survey administered in October 2017. The piece is titled "Smoking, Vaping, and Use of Edibles and Other Forms of Marijuana Among U.S. Adults," and here are some of the notable findings:
Among all respondents, 14.6% reported marijuana use in the past year and 8.7% reported use in the past 30 days. The prevalence of marijuana use in the past year was 20% (95% CI, 17.9% to 22.2%) in states where recreational use is legal, 14.1% (CI, 12.6% to 15.6%) in states where medical use is legal, and 12% (CI, 10.7% to 13.4%) in states where no use is legal.
A total of 12.9% of respondents reported smoking marijuana, 6% reported using edibles, 4.7% reported vaping, 1.9% reported using concentrates, and 0.8% reported using topicals. Overall, 6.7% reported using multiple forms in the past year. Prevalence of any use was inversely related to age, with persons aged 18 to 34 years reporting the highest use.... Men were more likely than women to use marijuana in any form and to use multiple forms (Table 1). Reported use was similar among racial groups.
Among persons who used multiple forms, 53% reported smoking and using edibles whereas 31% reported smoking and vaping. The prevalence of use of edibles was 11% (CI, 9.4% to 12.6%) in states where recreational use is legal, 5.1% (CI, 4.1% to 6.0%) in states where medical use is legal, and 4.2% (CI, 3.4% to 4.9%) in states where no use is legal. Baked goods/pastries and candies were the most common forms of edibles used by U.S. adults.... A limitation of our study is that those who participated in an online survey cohort may differ from those who did not, limiting generalizability. Respondents also may have underreported rates of use.
Sunday, August 26, 2018
I just came across this recent research available on-line in "preprint" with the same title as this post and authored by a collection of researchers. Here is its abstract with its significant conclusion highlighted:
Background and Aims:
The evolving legal status of cannabis in the United States and other countries necessitates the development of evidence-based regulatory policies to minimize risks associated with cannabis misuse. A prominent public health concern is whether legalization will lead to an expansion of the illegal cannabis market, with illegal cannabis acting as an economic substitute. Empirical data on this data on this issue is virtually nonexistent. This study used a behavioral economic approach to investigate substitutability of legal and illegal cannabis in legalized catchment areas in the U.S.
Adult cannabis users (N=740; Mean age = 33.8; 52% female; 73% Caucasian) were recruited using an online crowdsourcing platform from U.S. states with legalized recreational cannabis. A modified substitution-based marijuana purchase task assessed cannabis consumption from concurrently available legal (e.g., a dispensary) and illegal (e.g., a dealer) sources. Participants indicated the amount of cannabis they would consume from each source while prices of the two options were either held constant ($10/gram) or escalated ($0-$60/gram). Consumption values were used in demand curve modeling to generate quantitative indices of price sensitivity and elasticity.
Both legal and illegal fixed-price cannabis options had significant positive cross-price elasticities (ps < .001). However, the legal alternative had a substantially greater effect on consumption and elasticity of illegal cannabis (∆elasticity = 0.0018; F(1,37) = 148, p<.0001) than the opposite scenario (∆elasticity = 0.0002; F(1,37) = 47, p<.0001), indicating asymmetric substitution. Demand for legal cannabis was significantly greater than illegal cannabis (p< .0001).
Cannabis users treat legal cannabis as a superior commodity compared to illegal cannabis and exhibit asymmetric substitutability. Cannabis price policies that include higher consumer costs for legal cannabis relative to contraband would not be expected to incentivize and expand the illegal cannabis market.
Wednesday, August 22, 2018
I have been somewhat suspicious of some assertions by some marijuana reform advocates that legalization would actually produce lower rates of marijuana use by young people (whose developing brains are most at risk of being harmed by significant marijuana use). But, as reported her at Marijuana Moment, there is new data from California to support these kinds of claims:
Marijuana use among junior high and high school students is down across all age levels in California, according to the first survey of teen drug consumption conducted in the state since voters legalized recreational cannabis.
Results of the Biennial State California Healthy Kids Survey are consistent with data from other states that have legalized marijuana, where students have also reported declining or flat cannabis use rates following the end of prohibition for adults. “Lifetime marijuana use was reported by 4%, 17%, and 32% of students by ascending grade, declines of 4 points in 7th [grade] and 6 points in both 9th and 11th [grades],” the survey’s authors found.
The rates of alcohol and other drug use have been on steady downward trends since at least 2011, according to the survey. Recreational legalization after voters’ approval in 2016 didn’t interrupt that decline, nor did the growth of the medical cannabis market in the preceding years.
Teens indicated in the survey that a combination of peer and parental disapproval is discouraging them from using cannabis, with the number of seventh- and ninth-graders who said that they strongly disapproved of peer marijuana smoking increasing most sharply.
Results of the survey include data collected between 2015, before 57 percent of California voters approved Proposition 64, which immediately legalized cannabis for adults 21 and over in November 2016, and 2017. While commercial medical cannabis sales have been widespread in the state for years, the new study does not take into account any potential effect from legal recreational commerce, which began on January 1 of this year.
“How the recent legalization of marijuana use for adults in California effects the declining trend among youth warrants attention,” the survey’s authors wrote. “The next biennial survey will be of particular interest to shed light on whether the change in state marijuana laws affect these findings.” ....
The survey was conducted by the California Department of Education and the California Department of Health Care Services.
Thursday, August 9, 2018
A family trip has taken me off line for the last week, and so I feel way behind on marijuana reform news. But, as regular readers know, Marijuana Moment is a consistently informative (pro-reform) marijuana news site. As I was catching up, I thought these stories from the last week on that site were particularly noteworthy:
August 9, 2018 in Criminal justice developments and reforms, Medical Marijuana State Laws and Reforms, Recreational Marijuana Data and Research, Recreational Marijuana State Laws and Reforms | Permalink | Comments (0)
Thursday, July 26, 2018
The pro-marijuana reform website Marijuana Moment continues to provide effective coverage of all sorts of marijuana news and stories, and recently the site has spotlighted a lot of interesting new research results in these pieces:
Wednesday, July 25, 2018
It should not be surprising to see a significant drop in felony marijuana prosecutions after a jurisdiction legalizes the drug. But this new local article reporting on data from Washington highlights how dramatic the drop has been in one state. The article is headlined "After Legalization, A Nearly 90 Percent Drop In Marijuana Felony Convictions," and here are excerpts (with a few sentences emphasized):
The legalization of recreational marijuana in Washington state in 2012 resulted in a dramatic decrease in the number of people sentenced for marijuana-related felonies, according to an analysis conducted for public radio by the Washington State Caseload Forecast Council.
Between June 2008 and December 2009, the analysis showed, there were 1,312 offenses committed that resulted in felony sentences for the manufacture, delivery or possession with the intent to deliver marijuana. By contrast, during an 18 month period following the opening of recreational marijuana stores in 2014, there were just 147 marijuana-related crimes that resulted in felony level sentences--a nearly 90 percent decrease....
The sharp drop in felony-level marijuana sentences in Washington is not a surprise to Tom McBride, the executive director of the Washington Association of Prosecuting Attorneys. In an email, McBride said a decline in prosecutions was "expected" and "desired" by the public. He added that legalization had also made it more difficult to establish probable cause in delivery to minors or black market marijuana-related cases "because presence, odor, etc of marijuana can be legal or not."
Steve Strachan, executive director of the Washington Association of Sheriffs and Police Chiefs, also said the reduction in prosecutions was to be expected. But he added that a de-emphasis on marijuana enforcement, in part because of the rise in heroin and fentanyl cases, was resulting in more black market marijuana grows with ties to organized crime. “We need to direct more resources to the illicit [marijuana] grows that we are seeing across the state,” Strachan said in an email.
Of the 1,312 felony marijuana sentences that stemmed from offenses committed between June 2008 and December 2009, the vast majority, 1,217, were for first-time offenses, 76 were for subsequent offenses, 17 were for marijuana-related felonies in a school zone and two were for delivery or possession in a correctional facility.
By contrast, between December 2014 and June 2016, after marijuana stores opened, the number of marijuana crimes resulting in felony sentences for a first offense dropped to 145, there were no sentences for subsequent offenses or for selling marijuana in a school zone, and just one felony sentence related to marijuana in a correctional facility.
The Caseload Forecast Council, which helps the state plan for growth in entitlements, picked those particular date ranges to account for several factors including: the time lapse between the date of an offense and the date of the sentencing, and the length of time between when I-502 passed and the start of retail sales.
Data showing sentences for misdemeanor level marijuana crimes was not immediately available.
I think it especially notable that this data reveals how many first offenders were being brought into the criminal justice system prior to marijuana reform for felony offenses. But I would love to also see (a) what kinds of sentences felony offenders were getting both before and after legalization, as well as (b) prosecutions and sentences for misdemeanor marijuana offenses both before and after legalization. These felony data provides one snapshot of how marijuana reform impacts the criminal justice footprint of one part of the war on drugs, but a lot more data (and time) is needed to fully take stock of what a difference legalization laws can make.
Tuesday, July 24, 2018
Tom Angell reports here at Forbes on the introduction of a new piece of federal legislation that I consider long overdue. Here are the details:
The Marijuana Data Collection Act, introduced on Tuesday by Rep. Tulsi Gabbard (D-HI) and a bipartisan group of cosponsors, would direct the Department of Health and Human Services to partner with other federal and state government agencies to study "the effects of State legalized marijuana programs on the economy, public health, criminal justice and employment."...
If the legislation is enacted, the National Academy of Sciences would carry out the research and publish initial findings within 18 months, with follow-up reports to be issued every two years after that.
So far, the bill's backers seem to consist solely of those who support marijuana law reform, a situation that legalization advocates decried. “This is not a marijuana bill, it is an information bill," Justin Strekal, political director for NORML, said in an interview. "No member of Congress can intellectually justify opposition to this legislation. Our public policy needs to be based on sound data and science, not gut feelings or fear-mongering. Approving the Marijuana Data Collection Act would provide legislators with reliable and fact-based information to help them decide what direction is most beneficial to society when it comes to marijuana policy.”...
Gabbard held a Tuesday morning press conference with other supporters, including lead GOP cosponsor Rep. Carlos Curbelo (R-FL) and former U.S. Attorneys Barry Grissom of Kansas and Bill Nettles of South Carolina. Other original cosponsors of the bill include Reps. Don Young (R-AK), Darren Soto (D-FL), Beto O’Rourke (D-TX), Earl Blumenauer (D-OR), Dana Rohrabacher (R-CA), Matt Gaetz (R-FL), Peter DeFazio (D-OR), Eleanor Holmes Norton (D-DC), Dina Titus (D-NV), Charlie Crist (D-FL), Tom Garrett (R-VA), Lou Correa (D-CA), Barbara Lee (D-CA), Mark Pocan (D-WI) and Salud Carbajal (D-CA).
Here are the specific data points the bill directs federal officials to track:
REVENUES AND STATE ALLOCATIONS
The monetary amounts generated through revenues, taxes, and any other financial benefits. The purposes and relative amounts for which these funds were used. The total impact on the State and its budget.
MEDICINAL USE OF MARIJUANA
The rates of medicinal use among different population groups, including children, the elderly, veterans, and individuals with disabilities. The purpose of such use. Which medical conditions medical marijuana is most frequently purchased and used for.
The rates of overdoses with opioids and other painkillers. The rates of admission in health care facilities, emergency rooms, and volunteer treatment facilities related to overdoses with opioids and other painkillers. The rates of opioid-related and other painkiller-related crimes to one’s self and to the community. The rates of opioid prescriptions and other pain killers.
IMPACTS ON CRIMINAL JUSTICE
The rates of marijuana-related arrests for possession, cultivation, and distribution, and of these arrests, the percentages that involved a secondary charge unrelated to marijuana possession, cultivation, or distribution, including the rates of such arrests on the Federal level, including the number of Federal prisoners so arrested, disaggregated by sex, age, race, and ethnicity of the prisoners; and the rates of such arrests on the State level, including the number of State prisoners so arrested, disaggregated by sex, age, race, and ethnicity. The rates of arrests and citations on the Federal and State levels related to teenage use of marijuana. The rates of arrests on the Federal and State levels for unlawful driving under the influence of a substance, and the rates of such arrests involving marijuana. The rates of marijuana-related prosecutions, court filings, and imprisonments. The total monetary amounts expended for marijuana-related enforcement, arrests, court filings and proceedings, and imprisonment before and after legalization, including Federal expenditures disaggregated according to whether the laws being enforced were Federal or State. The total number and rate of defendants in Federal criminal prosecutions asserting as a defense that their conduct was in compliance with applicable State law legalizing marijuana usage, and the effects of such assertions.
The amount of jobs created in each State, differentiating between direct and indirect employment. The amount of jobs expected to be created in the next 5 years, and in the next 10 years, as a result of the State’s marijuana industry.
Because I cannot yet find the full text of the bill on-line, I cannot yet provide a full informed opinion on its particulars. I can say that I think a big, data-focused federal study of the impact of state marijuana reform is looooooooong overdue. I was hopeful, but not optimistic, that Prez Obama might see the wisdom and political value of pushing for this kind of study effort after the issuance of the 2013 Cole Memo and after the 2014 election brought more states and DC into the recreational marijuana column. But, sadly, we have been left largely with national number crunching by partisan advocates rather than government bean-counters for now two decades of ever-more-robust state-level reforms.
Based on Tom's description of the "Marijuana Data Collection Act," I am a bit concerned that there are not provisions likely to encourage pot prohibitionists to be supportive of this particular study effort. The folks at SAM are often eager to stress data on black markets, increased use of marijuana by workers, increased hospital visits, increased homelessness, increased drugged driving, increased use by youths and young adults, environmental impacts, and all sorts of other concerns (see, e.g., this SAM "lessons learned" report from March 2018). It is unclear if these kinds of potentially negative data are fundamental parts of the inquiry imagined by Marijuana Data Collection Act. If not, I doubt opponents of marijuana reform will want to sign on to this bill.
That said, even if the current version of the "Marijuana Data Collection Act" is in someway incomplete or one-sided, I hope a lot of folks on all sides of the marijuana reform debate will be inclined to try to make the bill better and get it passed. I sincerely hope nobody disagrees with the notion that sound data and science is needed in this arena, and I sense both sides of the debate sincerely believe that the data, if fairly collected, will be on their side. So maybe all can come together to really work toward trying to have all the data fairly collected (though I am not holding my breath).
July 24, 2018 in Campaigns, elections and public officials concerning reforms, Federal Marijuana Laws, Policies and Practices, Medical Marijuana Data and Research, Recreational Marijuana Data and Research, Who decides | Permalink | Comments (0)
Monday, July 23, 2018
Late last week the Auditor General of Pennsylvania released this notable report on “Regulating and Taxing Marijuana” that reads a bit more like an advocacy group's document than something that would emerge from a state government office. But, as this press release about the report reveals, the Auditor General of PA seems real eager to have access to a new revenue source:
Auditor General Eugene DePasquale today said Pennsylvania is missing out on $581 million per year in revenue by not regulating and taxing marijuana — money that could fund critical initiatives that affect Pennsylvanians’ lives. “Repeated polls have shown that a majority of Americans now believe marijuana should be legalized. In Pennsylvania, it’s 56 percent,” DePasquale said during a news conference with Pittsburgh Mayor William Peduto.
“Today, I’m releasing a special report that shows the staggering amount the state could reap in tax revenue if legislators simply did what their constituents want them to do: regulate and tax marijuana for adult use.”
The 14-page special report, “Regulating and Taxing Marijuana,” compiles national research data, which show that an average of 8.38 percent of the commonwealth’s adults (21 and older) currently use marijuana at least monthly — a total of 798,556 adults. In Colorado and Washington, where marijuana has been legal since 2012, adult users spend an average of $2,080 annually. If Pennsylvania’s 798,556 adult users spent the same amount, they would create a $1.66 billion retail industry.
Assuming Pennsylvania taxed the growth, cultivation and sale of marijuana at 35 percent, the state would collect roughly $581 million in tax revenue annually. If Allegheny and Philadelphia counties were allowed to add 1-2 percent local tax, they could collect an additional $3.8 million and $6.9 million, respectively. “Imagine what that $581 million could mean for Pennsylvanians,” DePasquale said. “Not only would it help balance the state budget, but it would also mean increases to initiatives that affect Pennsylvanians’ lives, such as greater access to opioid treatment and better health care access for veterans and children.”
DePasquale became the first statewide elected official to endorse regulating and taxing marijuana in March 2017. “With our neighboring states all looking at legalizing marijuana, now is the time for Pennsylvania to do the same,” DePasquale continued. “Legislators must act now so that we can be competitive and not lose potential revenue to other states.”
July 23, 2018 in Campaigns, elections and public officials concerning reforms, Recreational Marijuana Commentary and Debate, Recreational Marijuana Data and Research, Recreational Marijuana State Laws and Reforms, Taxation information and issues , Who decides | Permalink | Comments (0)